Central Nervous System Models | Charles River Discovery Research Services

Multiple Sclerosis (MS) Models 

Charles River Discovery Services’ model platform for multiple sclerosis (MS) focuses on induction of experimental allergic encephalomyelitis (EAE) in rats and mice. EAE is induced via injection of an inoculum containing either myelin oligodendrocyte glycoprotein (MOG) or proteolipid protein (PLP) in order to produce acute or chronic forms of the disease. Models include acute, progressive or relapsing-remitting disease course with elements of inflammation and neurodegeneration, components relevant to human MS.

Models for Multiple Sclerosis (MS)

  • Acute EAE in Rats
  • Chronic MOG-induced EAE in Rats
  • Chronic MOG-induced EAE in Mice
  • Chronic PLP-induced EAE in Mice


Example Study Paradigm of MOG-Induced EAE in Mice

Diagram outlining an example study paradigm using our MOG-Induced EAE mouse model of Multiple Sclerosis (MS)

 

Click here to see a diagram outlining an example study paradigm using our MOG-Induced EAE mouse model.


Data

 

EAE disease course during 50 days after MOG(35-55) inoculation in naive, EAE and EAE+copaxone treated mice

 

 

 

 

EAE disease course during 50 days after MOG35-55 inoculation
in naive, EAE and EAE+copaxone treated mice 
 

TNF-alpha levels in brain at 55 days after MOG(35-55) inoculation in naive and EAE mice


TNF-α levels in brain at 55 days after MOG35-55 inoculation in naive and EAE mice

 

TNF-alpha levels in spinal cord at 55 days after MOG(35-55) inoculation in naive and EAE mice



TNF-α levels in spinal cord at 55 days after MOG35-55 inoculation in naive and EAE mice

 

 

Demyelination in rat spinal cord at 50 days after MOG(1-116) inoculation

Demyelination in rat spinal cord at 50 days after MOG1-116 inoculation

For more information about our models used to research multiple sclerosis, please contact us at askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

+33 (0)4 74 01 69 69
askcharlesriver@crl.com

view all

News & Events

view all
mai 14 - New Models for Evaluating COPD or ...
mai 11 - Expert Safety Testing to Accelerat...
juin 14-juin 14 - Hørsholm, Denmark - Biotech Outsourcing Strategies (chemistry, manufa...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA, US

Charles River Laboratories, Inc.